Zurcher Kantonalbank (Zurich Cantonalbank) - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$718,976
-12.2%
22,738
+13.2%
0.00%
-25.0%
Q2 2023$818,944
+21.1%
20,082
+10.7%
0.00%
+33.3%
Q1 2023$676,413
+15.3%
18,149
+7.9%
0.00%0.0%
Q4 2022$586,850
-33.5%
16,820
+6.6%
0.00%
-40.0%
Q3 2022$883,000
+9.8%
15,777
+1.6%
0.01%0.0%
Q2 2022$804,000
-31.9%
15,530
-4.4%
0.01%
-16.7%
Q1 2022$1,181,000
-37.9%
16,253
+1.1%
0.01%
-33.3%
Q4 2021$1,901,000
+3.8%
16,079
+17.8%
0.01%
-10.0%
Q3 2021$1,832,000
-11.8%
13,655
+6.5%
0.01%
-16.7%
Q2 2021$2,076,000
+124.2%
12,823
+11.1%
0.01%
+140.0%
Q1 2021$926,000
+174.8%
11,540
+86.0%
0.01%
+150.0%
Q4 2020$337,000
+212.0%
6,203
+14.3%
0.00%
+100.0%
Q3 2020$108,000
-5.3%
5,4250.0%0.00%0.0%
Q2 2020$114,000
+200.0%
5,425
+73.5%
0.00%
Q1 2020$38,000
+52.0%
3,126
+84.3%
0.00%
Q4 2019$25,000
+8.7%
1,6960.0%0.00%
Q3 2019$23,000
+9.5%
1,696
+34.9%
0.00%
Q2 2019$21,0000.0%1,2570.0%0.00%
Q1 2019$21,000
-73.1%
1,257
-78.1%
0.00%
-100.0%
Q4 2018$78,000
-52.4%
5,7330.0%0.00%0.0%
Q3 2018$164,000
+4.5%
5,7330.0%0.00%0.0%
Q2 2018$157,000
+685.0%
5,733
+519.1%
0.00%
Q1 2018$20,000
+11.1%
9260.0%0.00%
Q4 2017$18,0009260.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders